Find the right Medicare plan for 2026 — compare coverage and costs in minutes.

Compare Medicare Plans →
Medicare News MedCity News

Three Ways Distressed Healthcare Must Evolve

What healthcare needs now is a connected, deeply integrated system of action that works with the system of record to complete work across the enterprise, supported by accountable partners willing to stand behind the outcomes they create. The post Three Ways Distressed Healthcare Must Evolve appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Why General Catalyst Is Betting $450M on Function Health’s Preventive Care Push

Function Health raised $450 million in growth financing from General Catalyst’s Customer Value Fund, just eight months after its $298 million Series B. The lab-testing startup plans to use the capital to expand access to its testing and imaging services. The post Why General Catalyst Is Betting $450M on Function Health’s Preventive Care Push appeared first on MedCity News .

Read full article →
Medicare News MedCity News

We Are Rats; If Pharma Could Be Brave … And Other Bullseye POVs You Won’t Hear at Other Events

MedCity News’ new event for healthcare investors and corporate business development leads — Bullseye — hit the mark when it comes to provocative and thoughtful commentary. Here’s what was said in panels throughout the day. The post We Are Rats; If Pharma Could Be Brave … And Other Bullseye POVs You Won’t Hear at Other Events appeared first on MedCity News .

Read full article →
Medicare News MedCity News

J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy

Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.85 billion. The deal puts J&J in the mix of pharmaceutical companies developing next-generation cell therapies for applications in autoimmune diseases. The post J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy appeared first on MedCity News .

Read full article →
Medicare News MedCity News

More Medications, Less Clarity: Strengthening Polypharmacy Support for CKD Patients

Interdisciplinary coordination between nephrologists, primary care providers, pharmacists, dieticians, and everyone who interacts with patients is essential to ensure patient education, improve adherence, and reduce medication errors. The post More Medications, Less Clarity: Strengthening Polypharmacy Support for CKD Patients appeared first on MedCity News .

Read full article →